TipRanks
OverviewSuggest Edit
TipRanks is a company providing a financial accountability engine that ranks financial advice to assess the accuracy and credibility of experts and analysts. The company's datasets are available through its website and a RESTful API.
| Type | Private | |
| Founded | 2012 | |
| HQ | Tel Aviv-Yafo, IL | Map |
| Website | tipranks.com |
Latest Updates
| Employees (est.) (Jun 2021) | 67 | (+5%) |
| Cybersecurity rating | B | More |
Key People/Management at TipRanks
Uri Gruenbaum
CEO and Co-Founder
Gilad Gat
CTO and Co-Founder
TipRanks Office Locations
TipRanks has an office in Tel Aviv-Yafo
Tel Aviv-Yafo, IL (HQ)
Maze St 56
TipRanks Financials and Metrics
Summary Metrics
Founding Date | 2012 |
TipRanks total Funding | $3 m |
TipRanks latest funding size | $3 m |
Time since last funding | 7 years ago |
TipRanks's latest funding round in July 2014 was reported to be $3 m. In total, TipRanks has raised $3 m
TipRanks Cybersecurity Score
TipRanks Online and Social Media Presence
19.23k Twitter followers
TipRanks has 19.23k Twitter Followers. The number of followers has increased 8% month over month and increased 77% quarter over quarter
TipRanks's Trends
Twitter Engagement Stats for @tipranks
22.8k
Tweets
1.2k
Following
19.2k
Followers
216
Tweets last 30 days
3.1
Avg. likes per Tweet
86.1%
Tweets with engagement
TipRanks News and Updates
May 04, 2021
Prytek invests in TipRanks
Technology group Prytek today announces it has made a significant investment in TipRanks as part of its wider investment strategy.
December 28, 2020
TipRanks says these five top Wall Street analysts win the year
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Sunrun & CrowdStrike
January 21, 2020
TipRanks Identifies the Top 25 Analysts of the Decade
NEW YORK, Jan. 21, 2020 /PRNewswire/ -- TipRanks, the world's leading analyst ranking service, has identified the Top 25 Wall Street analysts of the decade. The fintech company measures and ranks the performance of financial analysts to provide accountability and transparency. Over the...
TipRanks Blogs
June 18, 2021
William Blair Thinks Praxis Precision Medicines' Stock is Going to Recover
In a report issued on June 15, Myles Minter from William Blair reiterated a Buy rating on Praxis Precision Medicines (PRAX – Research Report). The company's shares closed last Friday at $21.52, close to its 52-week low of $17.68.
According to TipRanks.com, Minter is a 4-star analyst with an average…
June 18, 2021
William Blair Reaffirms Their Buy Rating on Phasebio Pharmaceuticals (PHAS)
In a report released yesterday, Matt Phipps from William Blair reiterated a Buy rating on Phasebio Pharmaceuticals (PHAS – Research Report). The company's shares closed last Friday at $3.75.
According to TipRanks.com, Phipps is a 3-star analyst with an average return of 5.7% and a 49.4% success rat…
June 18, 2021
Translate Bio (TBIO) Gets a Buy Rating from William Blair
William Blair analyst Myles Minter reiterated a Buy rating on Translate Bio (TBIO – Research Report) yesterday. The company's shares closed last Friday at $18.36.
According to TipRanks.com, Minter is a 4-star analyst with an average return of 17.2% and a 62.7% success rate. Minter covers the Health…
June 18, 2021
Aptinyx (APTX) Gets a Buy Rating from William Blair
William Blair analyst Myles Minter reiterated a Buy rating on Aptinyx (APTX – Research Report) on June 16. The company's shares closed last Friday at $3.10.
According to TipRanks.com, Minter is a 4-star analyst with an average return of 17.2% and a 62.7% success rate. Minter covers the Healthcare s…
June 18, 2021
William Blair Keeps a Buy Rating on Incyte (INCY)
William Blair analyst Matt Phipps reiterated a Buy rating on Incyte (INCY – Research Report) on June 14. The company's shares closed last Friday at $83.96.
According to TipRanks.com, Phipps is a 3-star analyst with an average return of 5.7% and a 49.4% success rate. Phipps covers the Healthcare sec…
June 18, 2021
William Blair Sticks to Their Buy Rating for Biogen (BIIB)
William Blair analyst Matt Phipps reiterated a Buy rating on Biogen (BIIB – Research Report) on June 15. The company's shares closed last Friday at $388.44.
According to TipRanks.com, Phipps is a 3-star analyst with an average return of 5.7% and a 49.4% success rate. Phipps covers the Healthcare se…
TipRanks Frequently Asked Questions
When was TipRanks founded?
TipRanks was founded in 2012.
Who are TipRanks key executives?
TipRanks's key executives are Uri Gruenbaum and Gilad Gat.
How many employees does TipRanks have?
TipRanks has 67 employees.
Who are TipRanks competitors?
Competitors of TipRanks include Moneyfacts.co.uk, Nordigen and AGS Health.
Where is TipRanks headquarters?
TipRanks headquarters is located at Maze St 56, Tel Aviv-Yafo.
Where are TipRanks offices?
TipRanks has an office in Tel Aviv-Yafo.
How many offices does TipRanks have?
TipRanks has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies